Mitsuharu Murase

518 total citations
43 papers, 361 citations indexed

About

Mitsuharu Murase is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, Mitsuharu Murase has authored 43 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Mitsuharu Murase's work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Chronic Kidney Disease and Diabetes (4 papers). Mitsuharu Murase is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Chronic Kidney Disease and Diabetes (4 papers). Mitsuharu Murase collaborates with scholars based in Japan and United States. Mitsuharu Murase's co-authors include Tatsuya Nishimiya, Akihiro Tanaka, Takashi Otsuka, Katsuya Suemaru, Tomoyoshi Inoue, Hiroaki Araki, Nozomu Takeuchi, Hitoshi Umezawa, Tetsuya Aiba and Hideichi Makino and has published in prestigious journals such as Endocrinology, Antimicrobial Agents and Chemotherapy and British Journal of Haematology.

In The Last Decade

Mitsuharu Murase

37 papers receiving 347 citations

Peers

Countries citing papers authored by Mitsuharu Murase

Since Specialization

Citations

This map shows the geographic impact of Mitsuharu Murase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuharu Murase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuharu Murase more than expected).

Fields of papers citing papers by Mitsuharu Murase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuharu Murase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuharu Murase. The network helps show where Mitsuharu Murase may publish in the future.

Co-authorship network of co-authors of Mitsuharu Murase

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuharu Murase. A scholar is included among the top collaborators of Mitsuharu Murase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuharu Murase. Mitsuharu Murase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differences of genetic diversity and antibiotics susceptibility of Pseudomonas aeruginosa isolated from hospital, river and coastal seawater 2010 ·Environmental Microbiology Reports ·Lisa Nonaka, (unknown), Hiroto Shinomiya, Mitsuharu Murase, Satoru Suzuki	15
2	Population Pharmacokinetic Analysis of Vancomycin Using Serum Cystatin C as a Marker of Renal Function 2009 ·Antimicrobial Agents and Chemotherapy ·Akihiro Tanaka, Tetsuya Aiba, Takashi Otsuka, Katsuya Suemaru, Tatsuya Nishimiya, Tomoyoshi Inoue, Mitsuharu Murase, Yuji Kurosaki, Hiroaki Araki	53
3	Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin 2008 ·Journal of Clinical Pharmacy and Therapeutics ·Takashi Otsuka, Akihiro Tanaka, Katsuya Suemaru, Tomoyoshi Inoue, Tatsuya Nishimiya, Mitsuharu Murase, Hiroaki Araki	7
4	Antimicrobial Susceptibility of Respiratory Tract Pathogens in Japan During PROTEKT Years 1–5 (1999–2004) 2008 ·Microbial Drug Resistance ·Matsuhisa Inoue, David J. Farrell, Kenichi Kaneko, (unknown), Shin‐ichi Fujita, Mitsuo Kaku, J Igari, Keizo Yamaguchi, (unknown), Mitsuharu Murase, Seishi Asari, Yoichi Hirakata, Hisashi Baba, (unknown)	20
5	Hoeks formula, a cystatin C-based prediction formula for determining the glomerular filtration rate, is the most effective method for adjusting the dosage of vancomycin 2007 ·International Journal of Clinical Pharmacology and Therapeutics ·Akihiro Tanaka, Katsuya Suemaru, Takashi Otsuka, (unknown), Tatsuya Nishimiya, Ikuya Sakai, Hiromasa Hasegawa, (unknown), Tomoyoshi Inoue, Mitsuharu Murase, Hiroaki Araki	12
6	Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–3 (1999–2002) 2006 ·Journal of Infection and Chemotherapy ·Matsuhisa Inoue, Kenichi Kaneko, (unknown), Shin‐ichi Fujita, Mitsuo Kaku, J Igari, Keizo Yamaguchi, Shigeru Kohno, Yoichi Hirakata, (unknown), Yoshitsugu Iinuma, Mitsuharu Murase, Takashi Yokoyama, Seishi Asari	33
7	Mutations of gyrA gene and parC gene in Streptococcus pneumoniae 2003 ·Kansenshogaku zasshi ·Hitoshi Miyamoto, Mitsuharu Murase	0
8	The absence of evidence for major effects of the frequent SNP +299G>A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetes 2003 ·Diabetes Research and Clinical Practice ·Masaaki Ochi, Haruhiko Osawa, Hiroshi Onuma, Akiko Murakami, Tatsuya Nishimiya, F Shimada, Kenichi Kato, Ikki Shimizu, (unknown), Mitsuharu Murase, Yasuhisa Fujii, Jun Ohashi, Hideichi Makino	20
9	URINARY TRACT INFECTION FOLLOWING RENAL TRANSPLANTATION 2002 ·Nozomu Tanji, (unknown), (unknown), Masayoshi Yokoyama, Hitoshi Miyamoto, Mitsuharu Murase	2
10	Gene Sequencing Analysis of DNA Gyrase and Topoisomerase IV as Levofloxacin Resistance in Streptococcus pneumoniae 2002 ·Kansenshogaku zasshi ·Hitoshi Miyamoto, Mitsuharu Murase	1
11	A complete deficiency of coagulation factor XIII A‐subunit due to a novel compound heterozygote of Ser 413 Leu missense and an nt 389 (ins G) frameshift mutation 1999 ·British Journal of Haematology ·Toshiyuki Niiya, Haruhiko Osawa, (unknown), (unknown), (unknown), (unknown), (unknown), Mitsuharu Murase, Kaichi Kida, Hideichi Makino	14
12	[Antimicrobial activities of roxithromycin against recently obtained clinical isolates]. 1997 ·PubMed ·J Igari, Toyoko Oguri, (unknown), Norihiko Misawa, Akio Nakamura, (unknown), (unknown), Yuka Nakamura, (unknown), (unknown), (unknown), Takeshi Mori, J Shimada, (unknown), Mitsuharu Murase, Yoichi Hirakata, Junichi Matsuda	1
13	Compositions of very low density lipoprotein subfractions from patients with polydisperse low density lipoproteins 1995 ·Clinica Chimica Acta ·Shuichi Saheki, Yasuo Hitsumoto, (unknown), Mitsuharu Murase, Nozomu Takeuchi, Kiyohisa Uchida	3
14	Decreased Susceptibility of Glycated Very Low Density Lipoproteins to Lipoprotein Lipase in vitro and Prevention by Glutathione 1994 ·Journal of Atherosclerosis and Thrombosis ·Shuichi Saheki, (unknown), Yasuo Hitsumoto, Mitsuharu Murase, Nozomu Takeuchi, Kiyohisa Uchida	1
15	In vitro degradation of very low density lipoprotein from diabetic patients by lipoprotein lipase 1993 ·Clinica Chimica Acta ·S Saheki, Yasuo Hitsumoto, Mitsuharu Murase, Nozomu Takeuchi, Kôji Uchida	9
16	Degradation of Apoproteins in High Density Lipoproteins with High or Low Contents of Amyloid A Proteins by Polymorphonuclear Leukocytes in Vitro 1990 ·Shuichi Saheki, Akira Takeda, (unknown), Isao Takahashi, Mitsuharu Murase, Nozomu Takeuchi	0
17	Changes in High Density Lipoproteins with High Content of Serum Amyloid A Protein by the Incubation with Polymorphonuclear Leucocytes 1989 ·Shuichi Saheki, Akira Takeda, (unknown), Mitsuharu Murase, (unknown)	0
18	High Density Lipoproteins in the Patients with High Serum Amyloid A Proteins 1988 ·Shuichi Saheki, Akira Takeda, Kenji Tokunaga, Mitsuharu Murase, Nozomu Takeuchi	0
19	Peptimycin,a product of streptomyces exhibiting apparent inhibition against Ehrlich carcinoma. 1961 ·Mitsuharu Murase	7
20	Identification of an antibiotic produced by S. galbus, n. sp. with streptomycin. 1959 ·PubMed ·Mitsuharu Murase, Toru Takita, (unknown), (unknown), Yoshirō Okami, Hitoshi Umezawa	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact